Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy

scientific article published on 3 July 2015

Recombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JMV.24317
P698PubMed publication ID26147509

P50authorAmr Shaaban HanafyQ64159909
P2093author name stringAhmad Mahmoud Hassaneen
Alaa Ahmad Farag
Hassan Mahmoud Hassanin
P2860cites workAn update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver DiseasesQ24632766
Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitisQ29619627
Immunogenicity of recombinant hepatitis B vaccine in treatment-naive and treatment-experienced chronic hepatitis C patients: the effect of pegylated interferon plus ribavirin treatmentQ33867600
Standards of medical care in diabetes--2011.Q34425055
Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complicationsQ35596530
Immunodominant viral peptides as determinants of cross-reactivity in the immune system--Can we develop wide spectrum viral vaccines?Q36211289
Hepatitis C genotype 4: What we know and what we don't yet know.Q37073708
Treatment predictors of a sustained virologic response in hepatitis B and C.Q37248066
Metabolic syndrome, non-alcoholic fatty liver disease and hepatitis C virus: impact on disease progression and treatment responseQ37383396
Hepatitis C and diabetes: the inevitable coincidence?Q37432092
Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in miceQ41756195
Hepatitis C virus modulates human monocyte-derived dendritic cellsQ41785343
High sustained virologic response rates in rapid virologic response patients in the large real-world PROPHESYS cohort confirm results from randomized clinical trialsQ42981362
Effect of sustained viral response on hepatic venous pressure gradient in hepatitis C-related cirrhosis.Q43038177
Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.Q44072943
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.Q44979610
Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity.Q45723479
Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cellsQ45748926
Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: a validation study based on follow-up.Q50764524
P433issue1
P921main subjectvirologyQ7215
P304page(s)86-93
P577publication date2015-07-03
P1433published inJournal of Medical VirologyQ15716684
P1476titleRecombinant HBV vaccine enhances the rate of sustained virological response when early initiated after anti-HCV combination therapy
P478volume88

Search more.